Accuray Incorporated
ARAY · NASDAQ
Market closed$0.259300$-0.006000 (-2.26%)After hours $0.264600 · +2.04%
Key statistics
Previous close$0.265300
Open$0.257500
Day high$0.259900
Day low$0.253100
52-week high$2.10
52-week low$0.240000
Market cap30.85M
Volume314.08K
Average volume3.38M
P/E ratio-0.70
Forward P/E—
EPS-0.37
Dividend yield0.00%
Market context
Why it moved
ARAY shares declined amid broad weakness in the tech sector, as growing skepticism around AI valuations and a "sell the news" sentiment triggered rotation away from technology-related equities.
What is happening
Recent company-specific developments and publisher coverage.
PR Newswire · May 29, 2026Accuray Incorporated Reports Inducement Award Under NASDAQ Listing RulesStock Titan · May 15, 202610-year Accuray–UW alliance aims to tailor radiation for cancer patientsSimply Wall Street · May 13, 2026Need To Know: Analysts Just Made A Substantial Cut To Their Accuray Incorporated (NASDAQ:ARAY) EstimatesInvesting.com · May 12, 2026Jefferies downgrades Accuray stock rating on guidance withdrawalInvesting.com · May 7, 2026BTIG downgrades Accuray stock rating on revenue challenges and guidance withdrawalPR Newswire · May 6, 2026Accuray Reports Fiscal 2026 Third Quarter Financial ResultsThe Globe and Mail · April 7, 2026Accuray Names Paul Miele Chief Commercial OfficerSimply Wall Street · February 6, 2026The Market Doesn't Like What It Sees From Accuray Incorporated's (NASDAQ:ARAY) Revenues Yet As Shares Tumble 33% Benzinga · May 15, 2026Accuray And The University of Wisconsin School of Medicine and Public Health Announce A New 10-Year Strategic Collaboration To Advance Personalized Cancer Treatments Using Accuray's Stellar Adaptive Radiation Therapy Platform Benzinga · May 12, 2026Jefferies Downgrades Accuray to Hold, Lowers Price Target to $0.35 Mt Newswire · May 12, 2026Accuray Shares Fall After Jefferies Downgrade Mt Newswire · May 12, 2026Jefferies Downgrades Accuray to Hold From Buy, Adjusts Price Target to $0.35 From $3.50 Benzinga · May 6, 2026Accuray Withdraws FY26 Financial Guidance As Geopolitical Uncertainty In Middle East Delays Installations, Materially Impacting Shipments And Service Revenue Benzinga · May 6, 2026Accuray Q3 EPS $(0.09) Misses $(0.04) Estimate, Sales $104.845M Miss $111.900M Estimate Benzinga · February 6, 2026Accuray Receives Nasdaq Noncompliance Notice, Gets Time Through Aug. 3 To Regain Compliance Benzinga · February 5, 2026BTIG Maintains Buy on Accuray, Lowers Price Target to $2